Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Altered White Matter Integrity after Mild to Moderate Traumatic Brain Injury.

Kim E, Seo HG, Lee HH, Lee SH, Choi SH, Cho WS, Wagner AK, Oh BM.

J Clin Med. 2019 Aug 27;8(9). pii: E1318. doi: 10.3390/jcm8091318.

2.

The Brazilian private pharmaceutical market after the first ten years of the generics law.

Bertoldi AD, Wagner AK, Emmerick ICM, Chaves LA, Stephens P, Ross-Degnan D.

J Pharm Policy Pract. 2019 Aug 14;12:18. doi: 10.1186/s40545-019-0179-9. eCollection 2019.

3.

Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program.

Leopold C, Araujo-Lane C, Rosenberg C, Gilkey M, Wagner AK.

Pharmacoecon Open. 2019 Jul 19. doi: 10.1007/s41669-019-0170-z. [Epub ahead of print] No abstract available.

4.

Extended (10-Day) Real-Time Monitoring by Dexamethasone-Enhanced Microdialysis in the Injured Rat Cortex.

Robbins EM, Jaquins-Gerstl A, Fine DF, Leong CL, Dixon CE, Wagner AK, Boutelle MG, Michael AC.

ACS Chem Neurosci. 2019 Aug 21;10(8):3521-3531. doi: 10.1021/acschemneuro.9b00145. Epub 2019 Jun 27.

PMID:
31246409
5.

Association of a Functional Polymorphism in the CHRFAM7A Gene with Inflammatory Response Mediators and Neuropathic Pain after Spinal Cord Injury.

Huang W, Kabbani N, Brannan TK, Lin MK, Theiss MM, Hamilton JF, Ecklund JM, Conley YP, Vodovotz Y, Brienza D, Wagner AK, Robbins E, Sowa GA, Lipsky RH.

J Neurotrauma. 2019 Nov 1;36(21):3026-3033. doi: 10.1089/neu.2018.6200. Epub 2019 May 23.

PMID:
30924722
6.

Characterization of human natural killer cells for therapeutic use.

Wagner AK, Alici E, Lowdell MW.

Cytotherapy. 2019 Mar;21(3):315-326. doi: 10.1016/j.jcyt.2018.11.001. Epub 2019 Mar 23.

PMID:
30910383
7.

A Repeated Measures Pilot Comparison of Trajectories of Fluctuating Endogenous Hormones in Young Women with Traumatic Brain Injury, Healthy Controls.

Niemeier JP, Perrin PB, Hurst BS, Foureau DM, Huynh TT, Evans SL, Silverman JE, Elise McClannahan M, Brusch BD, Newman M, Mougeot JL, Wagner AK.

Behav Neurol. 2019 Feb 12;2019:7694503. doi: 10.1155/2019/7694503. eCollection 2019.

8.

Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition.

Sottile R, Federico G, Garofalo C, Tallerico R, Faniello MC, Quaresima B, Cristiani CM, Di Sanzo M, Cuda G, Ventura V, Wagner AK, Contrò G, Perrotti N, Gulletta E, Ferrone S, Kärre K, Costanzo FS, Carlomagno F, Carbone E.

Front Immunol. 2019 Feb 26;10:224. doi: 10.3389/fimmu.2019.00224. eCollection 2019.

9.

Variability in daily self-reported emotional symptoms and fatigue measured over eight weeks in community dwelling individuals with traumatic brain injury.

Juengst SB, Terhorst L, Kew CL, Wagner AK.

Brain Inj. 2019;33(5):567-573. doi: 10.1080/02699052.2019.1584333. Epub 2019 Mar 5.

PMID:
30836017
10.

Comorbid Conditions Among Adults 50 Years and Older With Traumatic Brain Injury: Examining Associations With Demographics, Healthcare Utilization, Institutionalization, and 1-Year Outcomes.

Kumar RG, Olsen J, Juengst SB, Dams-OʼConnor K, OʼNeil-Pirozzi TM, Hammond FM, Wagner AK.

J Head Trauma Rehabil. 2019 Jul/Aug;34(4):224-232. doi: 10.1097/HTR.0000000000000470.

PMID:
30829819
11.

Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.

Frankel M, Fan L, Yeatts SD, Jeromin A, Vos PE, Wagner AK, Wolf BJ, Pauls Q, Lunney M, Merck LH, Hall CL, Palesch YY, Silbergleit R, Wright DW.

J Neurotrauma. 2019 Oct 15;36(20):2863-2871. doi: 10.1089/neu.2018.5809. Epub 2019 Jul 9.

PMID:
30794101
12.

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma.

Nahi H, Chrobok M, Gran C, Lund J, Gruber A, Gahrton G, Ljungman P, Wagner AK, Alici E.

PLoS One. 2019 Feb 13;14(2):e0211927. doi: 10.1371/journal.pone.0211927. eCollection 2019.

13.

Experimental traumatic brain injury results in estrous cycle disruption, neurobehavioral deficits, and impaired GSK3β/β-catenin signaling in female rats.

Fortress AM, Avcu P, Wagner AK, Dixon CE, Pang KCH.

Exp Neurol. 2019 May;315:42-51. doi: 10.1016/j.expneurol.2019.01.017. Epub 2019 Jan 31.

PMID:
30710530
14.

Computer-Aided Detection of Pulmonary Nodules in Computed Tomography Using ClearReadCT.

Wagner AK, Hapich A, Psychogios MN, Teichgräber U, Malich A, Papageorgiou I.

J Med Syst. 2019 Jan 31;43(3):58. doi: 10.1007/s10916-019-1180-1.

PMID:
30706143
15.

A mathematical model of neuroinflammation in severe clinical traumatic brain injury.

Vaughan LE, Ranganathan PR, Kumar RG, Wagner AK, Rubin JE.

J Neuroinflammation. 2018 Dec 18;15(1):345. doi: 10.1186/s12974-018-1384-1.

16.

Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh Vision.

Kochanek PM, Jackson TC, Jha RM, Clark RSB, Okonkwo DO, Bayır H, Poloyac SM, Wagner AK, Empey PE, Conley YP, Bell MJ, Kline AE, Bondi CO, Simon DW, Carlson SW, Puccio AM, Horvat CM, Au AK, Elmer J, Treble-Barna A, Ikonomovic MD, Shutter LA, Taylor DL, Stern AM, Graham SH, Kagan VE, Jackson EK, Wisniewski SR, Dixon CE.

J Neurotrauma. 2019 Feb 1. doi: 10.1089/neu.2018.6203. [Epub ahead of print]

PMID:
30520681
17.

Conjunctival melanoma.

Abreu MAMM, Tozo JP, Wagner AK.

An Bras Dermatol. 2018 Nov/Dec;93(6):936-937. doi: 10.1590/abd1806-4841.20187657. No abstract available.

18.

Factor structure of the Behavioral Assessment Screening Tool (BAST) in traumatic brain injury.

Juengst SB, Terhorst L, Wagner AK.

Disabil Rehabil. 2018 Nov 17:1-6. doi: 10.1080/09638288.2018.1496487. [Epub ahead of print]

PMID:
30451025
19.

Pharmaceutical system strengthening in Uganda: implementing a holistic, evidence-informed, long-term strategy.

Oteba M, Wagner AK, Seru M, Embrey M, Trap B.

J Pharm Policy Pract. 2018 Oct 15;11:23. doi: 10.1186/s40545-018-0150-1. eCollection 2018.

20.

TBI Rehabilomics Research: Conceptualizing a humoral triad for designing effective rehabilitation interventions.

Wagner AK, Kumar RG.

Neuropharmacology. 2019 Feb;145(Pt B):133-144. doi: 10.1016/j.neuropharm.2018.09.011. Epub 2018 Sep 14. Review.

PMID:
30222984
21.

Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs.

Gagne JJ, Popovic JR, Nguyen M, Sandhu SK, Greene P, Izem R, Jiang W, Wang Z, Zhao Y, Petrone AB, Wagner AK, Dutcher SK.

Drug Saf. 2018 Dec;41(12):1313-1323. doi: 10.1007/s40264-018-0709-4.

PMID:
30120741
22.

Employment Stability in the First 5 Years After Moderate-to-Severe Traumatic Brain Injury.

DiSanto D, Kumar RG, Juengst SB, Hart T, O'Neil-Pirozzi TM, Zasler ND, Novack TA, Dillahunt-Aspillaga C, Graham KM, Cotner BA, Rabinowitz AR, Dikmen S, Niemeier JP, Kesinger MR, Wagner AK.

Arch Phys Med Rehabil. 2019 Mar;100(3):412-421. doi: 10.1016/j.apmr.2018.06.022. Epub 2018 Jul 26.

PMID:
30055162
23.

Craniectomy and Craniotomy in Traumatic Brain Injury: A Propensity-Matched Analysis of Long-Term Functional and Quality of Life Outcomes.

Kelly ML, Shammassian B, Roach MJ, Thomas C, Wagner AK.

World Neurosurg. 2018 Oct;118:e974-e981. doi: 10.1016/j.wneu.2018.07.124. Epub 2018 Jul 24.

PMID:
30048790
24.

Estradiol to Androstenedione Ratios Moderate the Relationship between Neurological Injury Severity and Mortality Risk after Severe Traumatic Brain Injury.

Ranganathan P, Kumar RG, Oh BM, Rakholia MV, Berga SL, Wagner AK.

J Neurotrauma. 2019 Feb 15;36(4):538-547. doi: 10.1089/neu.2018.5677. Epub 2018 Sep 11.

PMID:
30014751
25.

Variability with Astroglial Glutamate Transport Genetics Is Associated with Increased Risk for Post-Traumatic Seizures.

Kumar RG, Breslin KB, Ritter AC, Conley YP, Wagner AK.

J Neurotrauma. 2019 Jan 15;36(2):230-238. doi: 10.1089/neu.2018.5632. Epub 2018 Sep 4.

PMID:
29999457
26.

Systemic Estrone Production and Injury-Induced Sex Hormone Steroidogenesis after Severe Traumatic Brain Injury: A Prognostic Indicator of Traumatic Brain Injury-Related Mortality.

Rakholia MV, Kumar RG, Oh BM, Ranganathan PR, Berga SL, Kochanek PM, Wagner AK.

J Neurotrauma. 2019 Apr 1;36(7):1156-1167. doi: 10.1089/neu.2018.5782. Epub 2018 Aug 24.

PMID:
29947289
27.

Quality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices.

Garabedian LF, Sinaiko AD, Ross-Degnan D, Abu-Jaber T, Hoefer M, Oddleifson S, Wagner AK.

Qual Manag Health Care. 2018 Jul/Sep;27(3):157-164. doi: 10.1097/QMH.0000000000000179.

PMID:
29944628
28.

Scholarly Research Projects Benefit Medical Students' Research Productivity and Residency Choice: Outcomes From the University of Pittsburgh School of Medicine.

Conroy MB, Shaffiey S, Jones S, Hackam DJ, Sowa G, Winger DG, Wang L, Boninger ML, Wagner AK, Levine AS.

Acad Med. 2018 Nov;93(11):1727-1731. doi: 10.1097/ACM.0000000000002328.

PMID:
29923890
29.

State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015.

Lu CY, Zhang F, Golonski N, Lupton C, Jeffrey P, Wagner AK.

Value Health. 2018 Jun;21(6):692-697. doi: 10.1016/j.jval.2017.09.011. Epub 2017 Nov 7.

30.

Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.

Leopold C, Wagner AK, Zhang F, Lu CY, Earle CC, Nekhlyudov L, Ross-Degnan D, Wharam JF.

Breast Cancer Res Treat. 2018 Sep;171(2):449-459. doi: 10.1007/s10549-018-4819-6. Epub 2018 Jun 1.

31.

Defining Value of Cancer Therapeutics-A Health System Perspective.

Leopold C, Peppercorn JM, Zafar SY, Wagner AK.

J Natl Cancer Inst. 2018 Jul 1;110(7):699-703. doi: 10.1093/jnci/djy079. Review.

PMID:
29788313
32.

Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.

Lu CY, Zhang F, Wagner AK, Nekhlyudov L, Earle CC, Callahan M, LeCates R, Xu X, Ross-Degnan D, Wharam JF.

Breast Cancer Res Treat. 2018 Aug;171(1):235-242. doi: 10.1007/s10549-018-4821-z. Epub 2018 May 12.

33.

Probabilistic Matching of Deidentified Data From a Trauma Registry and a Traumatic Brain Injury Model System Center: A Follow-up Validation Study.

Kumar RG, Wang Z, Kesinger MR, Newman M, Huynh TT, Niemeier JP, Sperry JL, Wagner AK.

Am J Phys Med Rehabil. 2018 Apr;97(4):236-241. doi: 10.1097/PHM.0000000000000838.

34.

Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment.

Wharam JF, Zhang F, Lu CY, Wagner AK, Nekhlyudov L, Earle CC, Soumerai SB, Ross-Degnan D.

J Clin Oncol. 2018 Apr 10;36(11):1121-1127. doi: 10.1200/JCO.2017.75.2501. Epub 2018 Feb 28.

35.

The effects of post-traumatic depression on cognition, pain, fatigue, and headache after moderate-to-severe traumatic brain injury: a thematic review.

Kumar RG, Gao S, Juengst SB, Wagner AK, Fabio A.

Brain Inj. 2018;32(4):383-394. doi: 10.1080/02699052.2018.1427888. Epub 2018 Jan 22. Review.

PMID:
29355429
36.

Development and content validity of the behavioral assessment screening tool (BASTβ).

Juengst SB, Terhorst L, Dicianno BE, Niemeier JP, Wagner AK.

Disabil Rehabil. 2019 May;41(10):1200-1206. doi: 10.1080/09638288.2017.1423403. Epub 2018 Jan 5.

PMID:
29303003
37.

Competency in supportive supervision: a study of public sector medicines management supervisors in Uganda.

Henry R, Nantongo L, Wagner AK, Embrey M, Trap B.

J Pharm Policy Pract. 2017 Oct 11;10:33. doi: 10.1186/s40545-017-0121-y. eCollection 2017.

38.

The pharmacogenomics of severe traumatic brain injury.

Adams SM, Conley YP, Wagner AK, Jha RM, Clark RS, Poloyac SM, Kochanek PM, Empey PE.

Pharmacogenomics. 2017 Oct;18(15):1413-1425. doi: 10.2217/pgs-2017-0073. Epub 2017 Oct 4. Review.

39.

TBI Rehabilomics Research: an Exemplar of a Biomarker-Based Approach to Precision Care for Populations with Disability.

Wagner AK.

Curr Neurol Neurosci Rep. 2017 Sep 19;17(11):84. doi: 10.1007/s11910-017-0791-5. Review.

PMID:
28929311
40.

Post-traumatic epilepsy associations with mental health outcomes in the first two years after moderate to severe TBI: A TBI Model Systems analysis.

Juengst SB, Wagner AK, Ritter AC, Szaflarski JP, Walker WC, Zafonte RD, Brown AW, Hammond FM, Pugh MJ, Shea T, Krellman JW, Bushnik T, Arenth PM.

Epilepsy Behav. 2017 Aug;73:240-246. doi: 10.1016/j.yebeh.2017.06.001. Epub 2017 Jun 26.

41.

A narrative literature review of depression following traumatic brain injury: prevalence, impact, and management challenges.

Juengst SB, Kumar RG, Wagner AK.

Psychol Res Behav Manag. 2017 Jun 14;10:175-186. doi: 10.2147/PRBM.S113264. eCollection 2017. Review.

42.

Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage.

Morgan SG, Leopold C, Wagner AK.

CMAJ. 2017 Jun 12;189(23):E794-E799. doi: 10.1503/cmaj.161481.

43.

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0.

Harun R, Grassi CM, Munoz MJ, Wagner AK.

J Vis Exp. 2017 Jun 5;(124). doi: 10.3791/55595.

44.

Expression of CD226 is associated to but not required for NK cell education.

Wagner AK, Kadri N, Snäll J, Brodin P, Gilfillan S, Colonna M, Bernhardt G, Höglund P, Kärre K, Chambers BJ.

Nat Commun. 2017 May 31;8:15627. doi: 10.1038/ncomms15627.

45.

A rapidly changing global medicines environment: How adaptable are funding decision-making systems?

Leopold C, Morgan SG, Wagner AK.

Health Policy. 2017 Jun;121(6):637-643. doi: 10.1016/j.healthpol.2017.04.002. Epub 2017 Apr 10.

PMID:
28449884
46.

Ventricular fibrillation cardiac arrest produces a chronic striatal hyperdopaminergic state that is worsened by methylphenidate treatment.

Nora GJ, Harun R, Fine DF, Hutchison D, Grobart AC, Stezoski JP, Munoz MJ, Kochanek PM, Leak RK, Drabek T, Wagner AK.

J Neurochem. 2017 Jul;142(2):305-322. doi: 10.1111/jnc.14058. Epub 2017 Jun 1.

47.

NK cells control breast cancer and related cancer stem cell hematological spread.

Tallerico R, Conti L, Lanzardo S, Sottile R, Garofalo C, Wagner AK, Johansson MH, Cristiani CM, Kärre K, Carbone E, Cavallo F.

Oncoimmunology. 2017 Feb 23;6(3):e1284718. doi: 10.1080/2162402X.2017.1284718. eCollection 2017.

48.

Cerebrospinal Fluid Cortisol Mediates Brain-Derived Neurotrophic Factor Relationships to Mortality after Severe TBI: A Prospective Cohort Study.

Munoz MJ, Kumar RG, Oh BM, Conley YP, Wang Z, Failla MD, Wagner AK.

Front Mol Neurosci. 2017 Mar 9;10:44. doi: 10.3389/fnmol.2017.00044. eCollection 2017.

49.

Cross-Lagged Panel Analysis of Depression and Behavioral Dysfunction in the First Year After Moderate-to-Severe Traumatic Brain Injury.

Juengst SB, Myrga JM, Fann JR, Wagner AK.

J Neuropsychiatry Clin Neurosci. 2017 Summer;29(3):260-266. doi: 10.1176/appi.neuropsych.16100217. Epub 2017 Mar 15.

50.

Payers' experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia.

Morgan SG, Vogler S, Wagner AK.

Health Policy. 2017 Apr;121(4):354-362. doi: 10.1016/j.healthpol.2017.02.002. Epub 2017 Feb 16.

Supplemental Content

Loading ...
Support Center